Uremic Bleeding: Pathogenesis and Therapy
- 1 August 1998
- journal article
- review article
- Published by Elsevier BV in The American Journal of the Medical Sciences
- Vol. 316 (2), 94-104
- https://doi.org/10.1097/00000441-199808000-00005
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Identification of guanidino succinate as a putative endogenous source of the endothelium derived relaxing factorBiochemical and Biophysical Research Communications, 1992
- Effect of human recombinant erythropoietin on bleeding time, platelet number and function in children with end-stage renal disease maintained by haemodialysisPediatric Nephrology, 1991
- Subcutaneous desmopressin (DDAVP) shortens the bleeding time in uremiaAmerican Journal of Hematology, 1989
- Dose-effect and pharmacokinetics of estrogens given to correct bleeding time in uremiaKidney International, 1988
- The role of nitric oxide and cGMP in platelet adhesion to vascular endotheliumBiochemical and Biophysical Research Communications, 1987
- Conjugated Estrogens for the Management of Bleeding Associated with Renal FailureNew England Journal of Medicine, 1986
- Deamino-8-D-Arginine Vasopressin Shortens the Bleeding Time in UremiaNew England Journal of Medicine, 1983
- Treatment of the Bleeding Tendency in Uremia with CryoprecipitateNew England Journal of Medicine, 1980
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980
- Ueber einen neuen Formbestandtheil des Blutes und dessen Rolle bei der Thrombose und der BlutgerinnungVirchows Archiv, 1882